S |
2020-02-12 16:11:22.0 |
ProQR Therapeutics N |
n/a |
ADAGE CAPITAL PARTNERS GP |
9.26% |
view |
B |
2020-01-28 11:34:42.0 |
ProQR Therapeutics N |
n/a |
WELLINGTON MANAGEMENT GROUP LLP |
11.13% |
view |
B |
2019-11-08 09:00:43.0 |
ProQR Therapeutics N |
n/a |
WELLINGTON MANAGEMENT GROUP LLP |
10.78% |
view |
B |
2019-02-13 13:41:54.0 |
ProQR Therapeutics N |
n/a |
ADAGE CAPITAL PARTNERS GP |
9.65% |
view |
B |
2018-05-25 16:27:30.0 |
ProQR Therapeutics N |
n/a |
ADAGE CAPITAL PARTNERS GP |
5.88% |
view |
B |
2018-04-12 17:29:37.0 |
ProQR Therapeutics N |
n/a |
Aescap Medical Investments B |
91.08% |
view |
B |
2016-04-08 14:29:23.0 |
ProQR Therapeutics N |
URGN |
Wildcat Capital Management |
5.51% |
view |
B |
2020-01-27 15:11:25.0 |
UroGen Pharma Ltd |
URGN |
WELLINGTON MANAGEMENT GROUP LLP |
6.15% |
view |
S |
2019-02-14 07:51:12.0 |
UroGen Pharma Ltd |
URGN |
Consonance Capital Management LP |
3.452% |
view |
S |
2018-02-14 10:55:45.0 |
UroGen Pharma Ltd |
URGN |
Consonance Capital Management LP |
10.0% |
view |
B |
2017-11-08 08:58:47.0 |
UroGen Pharma Ltd |
n/a |
MENORA MIVTACHIM HOLDINGS LTD |
11.5% |
view |